Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea

被引:10
|
作者
Tran, Nguyen Toan [1 ,2 ]
Jang, Myong Chon [3 ]
Choe, Yong Su [3 ]
Ko, Won Su [3 ]
Pyo, Hae Suk [4 ]
Kim, Ok Suk [4 ]
机构
[1] Int Planned Parenthood Federat, E SE Asia & Oceania Reg Off, Kuala Lumpur, Malaysia
[2] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia
[3] Korean Family Planning & Maternal & Child Hlth As, Pyongyang, North Korea
[4] Pyongyang Matern Hosp, Pyongyang, North Korea
关键词
Low-resource setting; Medical abortion; Mifepristone; Misoprostol; North Korea; PUBLIC-HEALTH; TRIAL; EXPERIENCES; MULTISITE; INDIA; CHINA; CUBA;
D O I
10.1016/j.ijgo.2010.01.012
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine the feasibility, efficacy, safety, and acceptability of medical abortion among rural and urban women up to 56 days of pregnancy in the Democratic People's Republic of Korea. Method: A total of 199 women (rural n = 95, urban n = 104) recruited from 2 rural and 2 urban reproductive health clinics received 200 mg of oral mifepristone followed 2 days later by 400 mu g of sublingual misoprostol. The women's abortion status and satisfaction level were determined 2 weeks later. Results: Overall complete abortion occurred in 96.0% of the women; there was no statistically significant difference between the groups (rural 95.8%, 95% confidence interval [Cl], 89.6-98.8; urban 96.2%, 95% Cl, 90.4-98.9). The 2 groups reported similar adverse effects. In total, 90.5% of rural and 88.5% of urban participants were satisfied or very satisfied with the method. Conclusion: The high efficacy and acceptability of medical abortion among rural and urban women suggest that medical abortion is a safe alternative to surgical abortion and can be scaled up to other reproductive health clinics in both rural and urban areas of the Democratic People's Republic of Korea, provided that there is appropriate training and supervision. (C) 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [1] Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam
    Ngoc, NTN
    Winikoff, B
    Clark, S
    Ellertson, C
    Am, KN
    Hieu, DT
    Elul, B
    [J]. INTERNATIONAL FAMILY PLANNING PERSPECTIVES, 1999, 25 (01): : 10 - +
  • [2] Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion
    Winikoff, B
    Sivin, I
    Coyaji, KJ
    Cabezas, E
    Xiao, BL
    Gu, SJ
    Du, MK
    Krishna, UR
    Eschen, A
    Ellertson, C
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (02) : 431 - 437
  • [3] Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria
    Okonofua, Friday
    Shittu, Oladapo
    Shochet, Tara
    Diop, Ayisha
    Winikoff, Beverly
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2014, 125 (01) : 49 - 52
  • [4] Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials
    Raghavan, Sheila
    Maistruk, Galina
    Shochet, Tara
    Bannikov, Vladimir
    Posohova, Svetlana
    Zhuk, Svetlana
    Lishchuk, Vladimir
    Winikoff, Beverly
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02): : 112 - 119
  • [5] Mifepristone-misoprostol medical abortion: Home administration of misoprostol in Guadeloupe
    Guengant, JP
    Bangou, J
    Elul, B
    Ellertson, C
    [J]. CONTRACEPTION, 1999, 60 (03) : 167 - 172
  • [6] Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh
    Alam, Anadil
    Bracken, Hillary
    Johnston, Heidi Bart
    Raghavan, Sheila
    Islam, Noushin
    Winikoff, Beverly
    Reichenbach, Laura
    [J]. INTERNATIONAL PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2013, 39 (02) : 79 - 87
  • [7] Mifepristone-misoprostol medical abortion: Who will use it and why?
    Blinder, V
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (05) : 1376 - 1376
  • [8] Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City
    Pena, Melanie
    Dzuba, Ilana G.
    Sanhueza Smith, Patricio
    Arellano Mendoza, Luis Jorge
    Bousieguez, Manuel
    Garcia Martinez, Maria Laura
    Rios Polanco, Ranulfo
    Flores Villalon, Antonio Eduardo
    Winikoff, Beverly
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2014, 127 (01) : 82 - 85
  • [9] OUTPATIENT MIFEPRISTONE-MISOPROSTOL MEDICAL ABORTION IHROUGH 77 DAYS OF GESTATION
    Dzuba, I
    Chong, E.
    Hann, C.
    Kurbanova, D.
    Lichtenberg, E. S.
    Hernandez, Lugo E. M.
    Thi Nhu Ngoc, N.
    Patel, A.
    Smith, Sanhueza P.
    Tsertsvadze, G.
    Winikoff, B.
    [J]. CONTRACEPTION, 2016, 94 (04) : 389 - 389
  • [10] Second Trimester Medical Abortion with Mifepristone-Misoprostol and Misoprostol Alone: A Review of Methods and Management
    Gewell-Danielsson, Kristina
    Lalitkumar, Sujata
    [J]. REPRODUCTIVE HEALTH MATTERS, 2008, 16 (31) : 162 - 172